POAI Stock Summary and Trading Ideas (Predictive Oncology | NASDAQ:POAI)

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Predictive Oncology trades on the NASDAQ stock market under the symbol POAI.

As of April 24, 2024, POAI stock price climbed to $1.34 with 23,809 million shares trading.

POAI has a beta of 3.46, meaning it tends to be more sensitive to market movements. POAI has a correlation of 0.10 to the broad based SPY ETF.

POAI has a market cap of $5.44 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, POAI stock traded as high as $32.80 and as low as $1.12.

The top ETF exchange traded funds that POAI belongs to (by Net Assets): VTI, VXF, DFAC.

POAI has underperformed the market in the last year with a price return of -64.2% while the SPY ETF gained +24.2%. POAI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -59.1% and -23.9%, respectively, while the SPY returned +4.6% and -2.7%, respectively.

POAI support price is $1.16 and resistance is $1.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that POAI stock will trade within this expected range on the day.